Use of off-label and unlicenced drugs in hospitalised paediatric patients: a systematic review Joana MagalhãesAntónio Teixeira RodriguesMaria Teresa Herdeiro Review Article 16 October 2014 Pages: 1 - 13
Pharmacokinetic interactions between simvastatin and setipiprant, a CRTH2 antagonist Martine GehinPatricia N. SidhartaJasper Dingemanse Clinical Trial 18 October 2014 Pages: 15 - 23
Population pharmacodynamic model for low molecular weight heparin nadroparin in morbidly obese and non-obese patients using anti-Xa levels as endpoint Jeroen DiepstratenEsther J. H. JanssenCatherijne A. J. Knibbe Pharmacodynamics 12 October 2014 Pages: 25 - 34
Clinical features of and genetic predisposition to drug-induced Stevens–Johnson syndrome and toxic epidermal necrolysis in a single Korean tertiary institution patients—investigating the relation between the HLA -B*4403 allele and lamotrigine Hye Jung ParkSung Ryeol KimJae-Hyun Lee Pharmacogenetics 21 October 2014 Pages: 35 - 41
Influence of PTGS1, PTGFR, and MRP4 genetic variants on intraocular pressure response to latanoprost in Chinese primary open-angle glaucoma patients Li-chen GaoDi WangJie Tang Pharmacogenetics 23 October 2014 Pages: 43 - 50
Effect of CYP2C19 polymorphisms on the clinical outcome of low-dose clobazam therapy in Japanese patients with epilepsy Sachiyo HashiIkuko YanoKazuo Matsubara Pharmacogenetics 18 October 2014 Pages: 51 - 58
A pharmacogenetic association between a variation in calpain 10 (CAPN10) gene and the response to metformin treatment in patients with type 2 diabetes Ivan TkáčMartin JavorskýViera Habalová Pharmacogenetics 21 October 2014 Pages: 59 - 63
The effect of food on the high clearance drug asenapine after sublingual administration to healthy male volunteers Peter DogteromRik de GreefPierre A. M. Peeters Pharmacokinetics and Disposition 01 January 2015 Pages: 65 - 74
Population pharmacokinetics of single-dose amikacin in critically ill patients with suspected ventilator-associated pneumonia C. BurdetO. PajotF. Mentré Pharmacokinetics and Disposition 21 October 2014 Pages: 75 - 83
N1-methylnicotinamide as an endogenous probe for drug interactions by renal cation transporters: studies on the metformin–trimethoprim interaction Fabian MüllerConstanza A. PontonesMartin F. Fromm Pharmacokinetics and Disposition 22 October 2014 Pages: 85 - 94
Population pharmacokinetics of mycophenolic acid and its main glucuronide metabolite: a comparison between healthy Chinese and Caucasian subjects receiving mycophenolate mofetil Jing LingJun ShiZheng Jiao Pharmacokinetics and Disposition 21 October 2014 Pages: 95 - 106
Linezolid versus vancomycin for the treatment of suspected methicillin-resistant Staphylococcus aureus nosocomial pneumonia: a systematic review employing meta-analysis Yan WangYamin ZouYalin Dong Pharmacoepidemiology and Prescription 30 October 2014 Pages: 107 - 115
Statin-induced muscle toxicity and susceptibility to malignant hyperthermia and other muscle diseases: a population-based case-control study including 1st and 2nd degree relatives Karin HedenmalmArzu Gunes GranbergMarja-Liisa Dahl Pharmacoepidemiology and Prescription 01 November 2014 Pages: 117 - 124
Revising the link between proton-pump inhibitors and risk of acute myocardial infarction—a case-crossover analysis Aleksandra TurkiewiczRaquel Perez VicenteJuan Merlo Pharmacoepidemiology and Prescription 12 November 2014 Pages: 125 - 129
